Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Pfizer Worldwide Research and Development, Cambridge, MA, USA.
Nat Immunol. 2019 Aug;20(8):980-991. doi: 10.1038/s41590-019-0425-y. Epub 2019 Jun 17.
Innate lymphoid cells (ILCs) are tissue-resident lymphocytes categorized on the basis of their core regulatory programs and the expression of signature cytokines. Human ILC3s that produce the cytokine interleukin-22 convert into ILC1-like cells that produce interferon-γ in vitro, but whether this conversion occurs in vivo remains unclear. In the present study we found that ILC3s and ILC1s in human tonsils represented the ends of a spectrum that included additional discrete subsets. RNA velocity analysis identified an intermediate ILC3-ILC1 cluster, which had strong directionality toward ILC1s. In humanized mice, the acquisition of ILC1 features by ILC3s showed tissue dependency. Chromatin studies indicated that the transcription factors Aiolos and T-bet cooperated to repress regulatory elements active in ILC3s. A transitional ILC3-ILC1 population was also detected in the human intestine. We conclude that ILC3s undergo conversion into ILC1-like cells in human tissues in vivo, and that tissue factors and Aiolos were required for this process.
先天淋巴细胞 (ILC) 是根据其核心调控程序和特征细胞因子表达分类的组织驻留淋巴细胞。体外培养时,产生细胞因子白细胞介素-22 的人 ILC3 可转化为产生干扰素-γ的 ILC1 样细胞,但这种转化是否发生在体内尚不清楚。在本研究中,我们发现人扁桃体中的 ILC3 和 ILC1 代表了一个包含其他离散亚群的连续谱的两端。RNA 速度分析鉴定出一个中间的 ILC3-ILC1 簇,该簇具有向 ILC1 强烈定向的特征。在人源化小鼠中,ILC3 获得 ILC1 特征表现出组织依赖性。染色质研究表明,转录因子 Aiolos 和 T-bet 合作抑制 ILC3 中活跃的调节元件。在人类肠道中也检测到了一个过渡性的 ILC3-ILC1 群体。我们的结论是,ILC3 在体内人组织中转化为 ILC1 样细胞,并且该过程需要组织因子和 Aiolos。